🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of stereotactic b...
Status
Completed
Location
University of Wisconsin Carbone Cancer Center
Start Date
2014-04-08
Trial ID
NCT01918644
Radiotherapy can activate local and systemic immune responses through a var...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04
Trial ID
NCT06914050
Treatments Being Tested
The purpose of this study is to compare the effectiveness and side effects ...
Status
Recruiting
Location
Verspeeten Family Cancer Centre
Start Date
2025-10-21
Trial ID
NCT07337161
Treatments Being Tested
Brain tumours are the commonest solid tumours in children and the second mo...
Status
Unknown
Location
Tata Memorial Centre
Start Date
2001-05
Trial ID
NCT00517959
Treatments Being Tested
This phase III trial compares stereotactic body radiation therapy (SBRT), (...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-12-14
Trial ID
NCT05946213
This phase II trial tests the effectiveness and safety of artificial intell...
Status
Recruiting
Location
Northwestern University
Start Date
2023-11-20
Trial ID
NCT05802186
The purpose of this study is to prospectively evaluate the feasibility of S...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2024-06-18
Trial ID
NCT05775146
Treatments Being Tested
This pilot phase I trial aims to investigate the safety and tolerability of...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2019-01-18
Trial ID
NCT03812549
Treatments Being Tested
The purpose of this study is to development of more effective treatment tac...
Status
Unknown
Location
National Center of Oncology
Start Date
2013-03
Trial ID
NCT03461822
A Single-Arm Clinical Study of Furmonertinib (160mg) Combined with Intrathe...
Status
Recruiting
Location
CANGZHOU People's Hospital
Start Date
2025-12-22
Trial ID
NCT07304739
Treatments Being Tested